ESLA

Estrella Immunopharma, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website estrellabio.com
Employees(FY) -
ISIN US2975841048

Performance

-6.07%

+36.31%

+20.19%

+42.86%

+4.5%

YTD

-7.19%

Profile

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Advanced Technical Analysis

Technical Analysis of ESLA 2024-12-20

The Moving Average Score of 70 indicates a bullish trend, while the Oscillators Score of 46 and the Technical Score of 58 suggest a more neutral sentiment overall. This combination implies a generally positive outlook for the stock, driven primarily by strong moving averages, but tempered by mixed signals from oscillators and technical indicators.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ESLA

Stock Rank

Recent News & Updates

2024-09-27 00:00
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS T-cells(Businesswire)
2024-08-14 00:00
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member(Businesswire)
2024-08-01 19:34
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-05-19 22:52
ESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024(Investorplace)
2023-09-28 22:34
TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination(Prnewswire)
2023-09-18 05:00
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination(Yahoo Finance)
2023-08-18 04:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination(Yahoo Finance)
2023-07-18 04:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination(Yahoo Finance)
2023-07-11 19:00
TradeUP Acquisition Corp. Announces Meeting Date for Stockholders to Approve the Business Combination with Estrella Biopharma, Inc. and Liquidation of Investments Held in the Trust Account into Cash(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.